Request a Pilot
About us

The people building genome-driven AMR care.

A clinical and computational team building a research prototype.

Team

Our scientists, engineers, and clinicians are building precision AMR diagnostics.

Different expertise. One system. One company. BactoAI is a multidisciplinary team building one AMR intelligence platform. The product, models, and technology belong to the company, and each of us leads a defined part of it.

Samwel Elegwa, Founder & CEO at BactoAI
Samwel Elegwa
Founder & CEO

Biotechnology researcher at Kenyatta University with hands-on analytical experience from a Kenya Bureau of Standards attachment in gravimetry, titrimetry, spectroscopy, and related laboratory methods. An alumnus of the NextGen Antimicrobial Stewards Initiative and 2nd-place finisher at Kenyatta University's Research in Science bootcamp, where BactoAI was first pitched.

Leads BactoAI's vision, scientific direction, and strategic growth, representing the company with hospitals, universities, funders, and antimicrobial stewardship networks across East Africa.

Vision & strategyScientific directionStrategic growth
Sheila Okwisa, Chief Technology Officer at BactoAI
Sheila Okwisa
Chief Technology Officer

Software engineer responsible for BactoAI's technology infrastructure and product development.

Leads the engineering architecture, cloud systems, and development workflows that transform BactoAI's scientific models and data pipelines into reliable, scalable software products.

Technology & engineeringCloud infrastructureProduct development
William Otieno, Machine Learning Engineer at BactoAI
William Otieno
Machine Learning Engineer

Electrical engineer specialising in applied machine learning and predictive analytics.

Leads the development, training, evaluation, and optimisation of BactoAI's machine-learning systems, working closely with the wider team to translate scientific and clinical requirements into reliable predictive tools.

Machine learningModel evaluationPredictive analytics
Sylvia Jane Nyambura, Chief Operating Officer at BactoAI
Sylvia Jane Nyambura
Chief Operating Officer

Leads BactoAI's day-to-day operations, pilot coordination, project execution, and organisational systems.

Connects the scientific, engineering, and partnership functions to ensure that projects move efficiently from development to real-world implementation.

OperationsPilot coordinationProject execution
Thomas Raphael Bonuke, Partnerships & Grants Lead at BactoAI
Thomas Raphael Bonuke
Partnerships & Grants Lead

Kenyatta University biotechnologist with laboratory training in molecular biology, virology and bacteriology at the National Veterinary Reference Laboratory. Led grants and partnerships for the Future Researchers Poster Summit.

Leads BactoAI's grant applications and builds partnerships with funders, hospitals and research institutions.

Grant writingFunder engagementInstitutional partnerships

Advisors & Partners

Dr George Orinda
Scientific Advisor
MicrobiologyAMRClinical validation
Dr. Thomas Musyoka, PhD
Bioinformatics Advisor
Computational biologyMLGenomics
Kenyatta Innovation Centre
Innovation Partner
CommercializationIncubationMentorship
Programmes & recognition

Recognised through Kenya and East Africa's innovation ecosystem

Developed through competitive innovation programmes in Kenya and East Africa, and recognised for translational health-tech impacts

CDIE Catalyst Grant
Grant
East Africa BioDesign
Programme
GEES Bootcamp
KU × Lancaster SET Workshop · 2nd place · March 2025
Kenyatta Innovation Centre
Incubation support
Partner with us

Let's build the AMR response of the next decade together.

We work with hospitals, sequencing providers, public-health agencies and academic groups. Tell us about your work and we'll respond within 2 business days.

  • · Access to our validation pipeline
  • · Co-authored clinical studies
  • · Custom AMR reports for your isolates
  • · Deployment support in low-resource labs

Your details stay private. We reply within 2 business days.

Validation partnerships

Join our clinical and research validation cohort.

We are seeking laboratories, hospitals and research groups to help validate BactoAI against real-world isolates.

Hospital & clinical labs

Compare BactoAI predictions with your existing susceptibility testing for meropenem, ciprofloxacin and cefotaxime.

Public health & surveillance

Explore genome-based AMR screening alongside your regional sequencing and surveillance work.

Academic & genomic research

Collaborate on validation studies and model evaluation using locally relevant bacterial isolates.

What pilot sites receive

  • A shared validation protocol agreed before work begins
  • Agreement analysis against your own laboratory results
  • Technical onboarding for your team
  • A joint review of pilot findings
Roadmap · 2026 →

From prototype to regional platform.

BIK Ventures pitch event · May 2026

Represented BactoAI at Kenyatta University's startup pitch showcase, with coverage in print and on BIK's channels.

Prototype completed

Working AI pipeline with initial antibiotic models.

Cloud deployment

Secure, scalable, browser-based platform.

Hospital pilots

Deployments with clinical partners in East Africa.

Clinical validation

Prospective studies on real clinical isolates.

Commercial launch

General availability for laboratories and hospitals.

East Africa expansion

Regional rollout & AMR surveillance partnerships.